111 Capital’s Tenet Healthcare THC Stock Holding History

111 Capital’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,387	Closed	-$244K	–	683
2025 Q2	$244K	Buy	+1,387	New	+$209K	0.04%	409

Other funds holding THC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

111 Capital's THC Position: Q3 2025 in Review

111 Capital sold out of Tenet Healthcare (THC) in Q3 2025, closing a stake of 1,387 shares — an estimated $244K sold.

111 Capital first reported a position in THC in Q2 2025 and held it in 1 quarter. The position peaked at $244K in Q2 2025. 680 funds tracked by Wall St. Rank hold THC as of Q3 2025.

111 Capital reported no remaining Tenet Healthcare position as of Q3 2025 after selling out during the quarter.
111 Capital sold 1,387 Tenet Healthcare shares in Q3 2025, an estimated $244K.
111 Capital first reported a position in Tenet Healthcare in Q2 2025 and held it in 1 quarter.
111 Capital's Tenet Healthcare position peaked at $244K in Q2 2025.
680 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2025.

Based on 111 Capital's 13F filing for Q3 2025, filed 12 Nov 2025.